Source:http://linkedlifedata.com/resource/pubmed/id/11983519
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2002-5-1
|
pubmed:abstractText |
56 biscationic dibromides with distinct polar heads [bis(4-substituted)pyridinium, bis(4-aminoquinolinium), bisquinolinium, and bisisoquinolinium moieties] and several spacers between the two charged nitrogen atoms were synthesised. This oriented synthesis produced 45 inhibitors of choline kinase with antitumour activity against the HT-29 cell line. In an attempt to understand the antiproliferative activity, a quantitative structure-activity relationship was developed. The unknown sigma(R) and sigma(R)(+) descriptors for the diallylamino, pyrrolidino, piperidino and perhydroazepino groups and sigma(R) for the N-methylanilino moiety, were estimated by (13)C NMR spectroscopy in a simple, fast and reproducible manner. The electron characteristic of the substituent at position 4 of the heterocycle and the theoretical lipophilic character of the whole molecule were found to significantly affect the antitumour activity. 1,1'-[Ethylenebis(benzene-1,4-diylmethylene)]bis[4-(N-methylanilino)pyridinium] dibromide is the most active compound of the series so far described and shows a reasonable agreement between predicted and observed antiproliferative data (predicted pIC(50)=6.50, experimental pIC(50)=6.46).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0968-0896
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2215-31
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11983519-Antineoplastic Agents,
pubmed-meshheading:11983519-Cell Division,
pubmed-meshheading:11983519-Choline Kinase,
pubmed-meshheading:11983519-Enzyme Inhibitors,
pubmed-meshheading:11983519-HT29 Cells,
pubmed-meshheading:11983519-Humans,
pubmed-meshheading:11983519-Magnetic Resonance Spectroscopy,
pubmed-meshheading:11983519-Quantitative Structure-Activity Relationship
|
pubmed:year |
2002
|
pubmed:articleTitle |
Quantitative structure-activity relationships for a series of symmetrical bisquaternary anticancer compounds.
|
pubmed:affiliation |
Departamento de Química Farmacéutica y Orgánica, Facultad de Farmacia, c/Campus de Cartuja s/n, 18071 Granada, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|